PharmAbcine Inc Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - PharmAbcine Inc

Watchlist Manager

Watchlist

Price: 2 915 KRW -8.91% Market Closed

Market Cap: ₩9.2B

P	PharmAbcine Inc KOSDAQ:208340	KR
	Iceni Gold Ltd ASX:ICL	AU
P	Pacific Conquest Holdings Inc OTC:PCHK	US
E	Eastern Technical Engineering Co Ltd SET:ETE	TH
	Abrau-Durso PAO MOEX:ABRD	RU
A	Ahlers AG DUS:AAH	DE
	Excite Technology Services Ltd ASX:EXT	AU
	Fine Foods & Pharmaceuticals NTM SpA MIL:FF	IT
	Lotus Ventures Inc OTC:LTTSF	CA
	Minotaur Exploration Ltd ASX:MEP	AU
	Leslie's Inc NASDAQ:LESL	US
	Tincorp Metals Inc OTC:TINFF	CA
	FEC Resources Inc OTC:FECOF	CA

Profitability Summary

PharmAbcine Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

40%

Low 3Y Average Gross Margin

Negative Operating Margin

-27%

Negative 3Y Average Operating Margin

-4 858%

Operating Margin is Increasing

-9 408% > -27%

Low Net Margin

Negative 3Y Average Net Margin

-6 027%

Net Margin is Increasing

-13 916% > 5%

Negative Free Cash Flow Margin

Negative 3Y Average Free Cash Flow Margin

-4 502%

Free Cash Flow Margin is Increasing

-6 726% > 0%

Low ROE

Negative 3Y Average ROE

Negative 3Y Average ROIC

-72%

ROIC is Increasing

-60% > -44%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.